Nanobiotix (Nanobiotix)

Oncology Corporate Profile

HQ Location

60 rue de Wattignies, Bat B
Paris, France 75012

Company Description

Nanobiotix is an oncology focused nanomedicine company developing an innovative nanoparticle technology. Nanobiotix is developing new tools for cancer which utilize a physical mode of action at the cellular level of the cancer cell. The NanoXray technology comprises three products having the potential to cause a paradigm shift in cancer therapy. Specifically, NanoXray products may overcome the current limitations of standard of care in local therapy.


This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
NBTXR3radiotherapeuticHead & Neck cancerI
NBTXR3radiotherapeuticHepatocellular carcinoma (HCC)I
NBTXR3radiotherapeuticVarious cancer typesI

View additional information on product candidates here »


Recent News Headlines

There are no news items to display